tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market
CCCC
C4 Therapeutics
RESEARCH TOOLSreports
Want to see CCCC full AI Analyst Report?

C4 Therapeutics (CCCC) Income Statement

670 Followers

C4 Therapeutics Income Statement

Last quarter (Q4 2025), C4 Therapeutics's total revenue was $11.02M, an increase of 112.79% from the same quarter last year. In Q4, C4 Therapeutics's net income was $-20.49M. See C4 Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 35.95M$ 35.58M$ 20.76M$ 31.10M$ 45.78M
Gross Profit
$ 27.97M$ 35.58M$ 13.02M$ 31.10M$ 45.78M
Operating Expenses
$ 132.46M$ 155.20M$ 152.05M$ 160.63M$ 127.92M
Depreciation and Amortization
$ 1.96M$ 1.82M$ 7.74M$ 1.68M$ 1.49M
EBITDA
$ -102.91M$ -103.37M$ -122.10M$ -124.28M$ -80.25M
Operating Income
$ -104.49M$ -119.61M$ -139.03M$ -129.53M$ -82.13M
Other Income/Expenses
$ -384.00K$ 14.43M$ 7.82M$ 1.36M$ -1.76M
Pretax Income
$ -104.87M$ -105.19M$ -131.21M$ -128.18M$ -83.89M
Net Income
$ -104.99M$ -105.32M$ -132.49M$ -128.18M$ -83.89M
Per Share Metrics
Basic EPS
$ -1.27$ -1.52$ -2.67$ -2.62$ -1.82
Diluted EPS
$ -1.27$ -1.52$ -2.67$ -2.62$ -1.82
Weighted Average Shares Outstanding
 82.89M 69.37M 49.64M 48.86M 46.04M
Weighted Average Shares Outstanding (Diluted)
 82.89M 69.37M 49.64M 48.86M 46.04M
Currency in USD

C4 Therapeutics Earnings and Revenue History